Literature DB >> 15154939

Development and progression of diabetic retinopathy in patients with Type 1 diabetes who are positive for GAD autoantibody.

T Mimura1, H Funatsu, Y Uchigata, S Kitano, E Shimizu, H Noma, S Amano, M Araie, Y Iwamoto, S Hori.   

Abstract

AIMS: To investigate the relationship between autoantibodies to glutamic acid decarboxylase (GAD) and proliferative diabetic retinopathy (PDR) to assess the role of autoimmunity in retinopathy.
METHODS: Patients with Type 1 diabetes for more than 10 years who had been diagnosed under age 30 (13-28 years) were studied. They were classified into three groups. The PDR group consisted of 22 patients, the pre-PDR group was 26 patients, while the non-DR group was 32 patients who had Type 1 diabetes without retinopathy. Blood was collected to measure autoantibodies to GAD, and the relationship between PDR and GAD positivity was investigated in a cross-sectional study.
RESULTS: The highest positivity rate of GAD autoantibodies was 50.0% in the non-DR group, followed by the pre-PDR group (30.8%) and the PDR group (18.2%).
CONCLUSIONS: Production or existence of GAD autoantibodies may contribute to the prevention of retinopathy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15154939     DOI: 10.1111/j.1464-5491.2004.01204.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  3 in total

1.  Anticardiolipin antibodies in proliferative diabetic retinopathy: An additional risk factor.

Authors:  Maha Shahin; Amany M El-Diasty; Mohamed Mabed
Journal:  Saudi J Ophthalmol       Date:  2009-08-05

2.  HLA genes, islet autoantibodies and residual C-peptide at the clinical onset of type 1 diabetes mellitus and the risk of retinopathy 15 years later.

Authors:  Richard A Jensen; Elisabet Agardh; Ake Lernmark; Soffia Gudbjörnsdottir; Nicholas L Smith; David S Siscovick; Carina Törn
Journal:  PLoS One       Date:  2011-03-11       Impact factor: 3.240

3.  Imaging and quantification of subbasal nerve plexus in healthy volunteers and diabetic patients with or without retinopathy.

Authors:  Andrey Zhivov; Karsten Winter; Marine Hovakimyan; Sabine Peschel; Volker Harder; Hans-Christof Schober; Guenther Kundt; Simone Baltrusch; Rudolf F Guthoff; Oliver Stachs
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.